We look forward to updating shareholders on future progress in due course.” Earlier in 2024, the company announced an agreement with AstraZeneca to evaluate the use of Optimer for targeted delivery of ...

PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

The decision to extend the transition period in South Sudan once again and postpone long-awaited elections cannot be “business as usual”, the UN Special Representative for the country told the ...